Portal de Periódicos da CAPES

Triple Negative and Basal-like Breast Cancer in East Africa

2011; Wiley; Volume: 17; Issue: 4 Linguagem: Inglês

10.1111/j.1524-4741.2011.01096.x

1524-4741

Mateya Trinkaus, Shahin Sayed, Samuel Gakinya, Zahir Moloo, Wedad Hanna, Yasmin Rahim,

Global Cancer Incidence and Screening

The Breast JournalVolume 17, Issue 4 p. 438-440 LETTER TO THE EDITOR Triple Negative and Basal-like Breast Cancer in East Africa Mateya E. Trinkaus MD, FRCPC, Mateya E. Trinkaus MD, FRCPC NHMRC Clinical Trials Centre, Sydney, AustraliaSearch for more papers by this authorShahin Sayed M.B.Ch.B, Shahin Sayed M.B.Ch.B Department of Pathology, Aga Khan University Hospital, Nairobi, KenyaSearch for more papers by this authorSamuel Mukono Gakinya M.B.Ch.B, Samuel Mukono Gakinya M.B.Ch.B Department of Pathology, Aga Khan University Hospital, Nairobi, KenyaSearch for more papers by this authorZahir Moloo MD, FRCPC, Zahir Moloo MD, FRCPC Department of Pathology, Aga Khan University Hospital, Nairobi, KenyaSearch for more papers by this authorWedad Hanna MBBCh, Wedad Hanna MBBCh Department of Pathology, Sunnybrook Health Sciences Centre, Toronto, Ontario, CanadaSearch for more papers by this authorYasmin Rahim MD, FRCPC, Yasmin Rahim MD, FRCPC Department of Medical Oncology and Hematology, Stronach Regional Cancer Centre, Newmarket, Ontario, CanadaSearch for more papers by this author Mateya E. Trinkaus MD, FRCPC, Mateya E. Trinkaus MD, FRCPC NHMRC Clinical Trials Centre, Sydney, AustraliaSearch for more papers by this authorShahin Sayed M.B.Ch.B, Shahin Sayed M.B.Ch.B Department of Pathology, Aga Khan University Hospital, Nairobi, KenyaSearch for more papers by this authorSamuel Mukono Gakinya M.B.Ch.B, Samuel Mukono Gakinya M.B.Ch.B Department of Pathology, Aga Khan University Hospital, Nairobi, KenyaSearch for more papers by this authorZahir Moloo MD, FRCPC, Zahir Moloo MD, FRCPC Department of Pathology, Aga Khan University Hospital, Nairobi, KenyaSearch for more papers by this authorWedad Hanna MBBCh, Wedad Hanna MBBCh Department of Pathology, Sunnybrook Health Sciences Centre, Toronto, Ontario, CanadaSearch for more papers by this authorYasmin Rahim MD, FRCPC, Yasmin Rahim MD, FRCPC Department of Medical Oncology and Hematology, Stronach Regional Cancer Centre, Newmarket, Ontario, CanadaSearch for more papers by this author First published: 14 July 2011 https://doi.org/10.1111/j.1524-4741.2011.01096.xCitations: 9 Address correspondence and reprint requests to: Mateya E. Trinkaus, MD, FRCPC, NHMRC Clinical Trials Centre, Sydney, Australia, or email: [email protected] Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Sørlie T, Perou CM, Tibshirani R, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 2001; 98: 10869. 2 Nofech-Mozes S, Trudeau M, Kahn HK, et al. Patterns of recurrence in the basal and non-basal subtypes of triple-negative breast cancers. Breast Cancer Res Treat 2009; 118: 131–7. 3 Dent R, Trudeau M, Pritchard KI, et al. Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res 2007; 13: 4429. 4 Foulkes WD, Stefansson IM, Chappuis PO, et al. Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer. J Natl Cancer Inst 2003; 95: 1482. 5 Atchley DP, Albarracin CT, Lopez A, et al. Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer. J Clin Oncol 2008; 26: 4282. 6 Young S, Pilarski RT, Donenberg T, et al. The prevalence of BRCA 1 mutations among young women with triple-negative breast cancer. BMC Cancer 2009; 9: 86. 7 Carey LA, Perou CM, Livasy CA, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 2006; 295: 2492. 8 Lund MJB, Butler EN, Bumpers HL, et al. High prevalence of triple negative tumors in an urban cancer center. Cancer 2008; 113: 608–15. 9 Stark A, Kleer CG, Martin I, et al. African ancestry and higher prevalence of triple negative breast cancer. Cancer 2010; 116: 4926–32. 10 Huo D, Ikpatt F, Khramtsov A, et al. Population differences in breast cancer: survey in indigenous African women reveals over-representation of triple-negative breast cancer. J Clin Oncol 2009; 27: 4515. 11 Gakinya S, Sayed S, Chauhan R, Sayed P. Breast cancer molecular subtypes and their clinicopathological characteristics amongst patients at the Aga Khan University hospital (Nairobi). Ann Afr Surg 2010; 5: 19–24. 12 Bird P, Hill A, Houssami N. Poor hormone receptor expression in East African breast cancer: evidence of a biologically different disease? Ann Surg Oncol 2008; 15: 1983–8. 13 Reddy JC, Reimann JD, Anderson SM, Klein PM. Concordance between central and local laboratory HER2 testing from a community-based clinical study. Clin Breast Cancer 2006; 7: 153–7. 14 Nyagol J, Nyong’o A, Byakika B, et al. Routine assessment of hormonal receptor and her-2/neu status underscores the need for more therapeutic targets in Kenyan women with breast cancer. Anal Quant Cytol Histol 2006; 28: 97. 15 Roy I, Othieno E. Breast carcinoma in Uganda: microscopic study and receptor profile of 45 cases. Arch Pathol Lab Med 2011; 135: 194–9. 16 Nalwoga H, Arnes JB, Wabinga H, Akslen LA. Frequency of the basal like phenotype in African breast cancer. APMIS 2007; 115: 1391–9. 17 Gordon NH. Socioeconomic factors and breast cancer in black and white Americans. Cancer Metastasis Rev 2003; 22: 55–65. 18 Stalsberg H, Awuah B, Ibarra JA, Nsiah-Asare A Reestablishing a surgical pathology service in Kumasi, Ghana: case report and discussion of barriers and key elements of a successful collaboration between low- and high-resource countries. Cancer. 2008; 113(Suppl. 8): 2338–46. 19 Masood S, Vass L, Ibarra JA Jr, et al. Breast pathology guideline implementation in low and middle income countries. Cancer 2008; 113: 2297–304. 20 Mbonde M, Amir H, Schwartz-Albiez R, Akslen L, Kitinya J. Expression of estrogen and progesterone receptors in carcinomas of the female breast in Tanzania. Oncol Rep 2000; 7: 277–83. 21 Burson AM, Soliman AS, Ngoma TA, et al. Clinical and epidemiologic profile of breast cancer in Tanzania. Breast Disease 2010; 31: 33–41. Citing Literature Volume17, Issue4July/August 2011Pages 438-440 ReferencesRelatedInformation